Details of the Drug
General Information of Drug (ID: DMN516S)
Drug Name |
2-pyridylethylamine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-(2-Aminoethyl)pyridine; 2706-56-1; 2-Pyridylethylamine; 2-(pyridin-2-yl)ethanamine; 2-(2-Pyridyl)ethylamine; 2-Pyridineethanamine; 2-pyridin-2-ylethanamine; Demethylbetahistine; alpha-Pyridylethylamine; 2-(pyridin-2-yl)ethan-1-amine; Lilly 04432; Pyridine, 2-(2-aminoethyl)-; UNII-ATW1AH7OJ5; Pyridineethanamine; 2-(2'-Aminoethyl)pyridine; NSC 71989; .alpha.-Pyridylethylamine; EINECS 220-295-1; ATW1AH7OJ5; 2-AMINOETHYLPYRIDINE; 2-(2-Pyridinyl)ethanamine; 2-(2-aminoethyl)-pyridine; 2-(2-aminoethyl) pyridine
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL is unavailable | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 122.17 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References